bioRxivMicrobiology
A nucleus-like compartment shields bacteriophage DNA from CRISPR-Cas and restriction nucleases
S. D. Mendoza, J. D. Berry, E. S. Nieweglowska, L. M. Leon, D. Agard, J. Bondy-Denomy
Abstract
All viruses require strategies to inhibit or evade the immunity pathways of cells they infect. The viruses that infect bacteria, bacteriophages (phages), must avoid nucleic-acid targeting immune pathways such as CRISPR-Cas and restriction endonucleases to replicate efficiently1. Here, we show that a jumbo phage infecting Pseudomonas aeruginosa, phage {Phi}KZ, is resistant to many immune systems in vivo, including CRISPR-Cas3 (Type I-C), Cas9 (Type II-A), Cas12 (Cpf1, Type V-A), and Type I restriction-modification (R-M) systems. We propose that {Phi}KZ utilizes a nucleus-like shell to protect its DNA from attack. Supporting this, we demonstrate that Cas9 is able to cleave {Phi}KZ DNA in vitro, but not in vivo and that Cas9 is physically occluded from the shell assembled by the phage during infection. Moreover, we demonstrate that the Achilles heel for this phage is the mRNA, as translation occurs outside of the shell, rendering the phage sensitive to the RNA targeting CRISPR-Cas enzyme, Cas13a (C2c2, Type VI-A). Collectively, we propose that the nucleus-like shell assembled by jumbo phages enables potent, broad spectrum evasion of DNA-targeting nucleases.
- organism: bacteria (other)
- assay: DNA methylation
- assay: CRISPR screen
- research focus: host-pathogen & immune response
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A phiKMV ligase-dependent DNA repair mechanism that mitigates DNA-targeting nucleases
Alexis Villani, Shweta Karambelkar, … Joseph Bondy‐Denomy·bioRxiv·Sep 23, 2026
- Type III CRISPR-Cas provides resistance against nucleus-forming jumbo phages via abortive infection
D. Mayo-Munoz, L. M. Smith, … P. C. Fineran·bioRxiv·Jun 20, 2022
- A nucleus-forming jumbophage evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity
L. M. Malone, S. L. Warring, … P. C. Fineran·bioRxiv·Sep 25, 2019
- CRISPR-Cas9 target-strand nicking provides phage resistance by inhibiting replication
Giang T. Nguyen, Akshara Raju, … Dipali G. Sashital·Nucleic Acids ResearchPeer-reviewed·Aug 27, 2025
- RNA targeting with CRISPR-Cas13a facilitates bacteriophage genome engineering
J. Guan, A. Oromi-Bosch, … J. Bondy-Denomy·bioRxiv·Feb 14, 2022
- A unique mode of nucleic acid immunity performed by a single multifunctional enzyme
S. M. N. Bari, L. Chou-Zheng, … A. Hatoum-Aslan·bioRxiv·Aug 30, 2021